New Review of Critical Decisions
A review of Critical Decisions was recently published in The American Journal of Bioethics. You can check it out here.
(Click here to view comments)
A review of Critical Decisions was recently published in The American Journal of Bioethics. You can check it out here.
(Click here to view comments)
KARAN: You referred to patient education earlier, not just in terms of treatment information but also the types of questions to be asking. But what about the former? Our generation is definitely comfortable using technology to look up health information, and we get a ton of information through news, magazines, and the general media. But…
Chemotherapy drugs have become ridiculously expensive. Many new drugs come to market costing more than $100,000 per patient for a full course of treatment. Often, patients have to pay a significant portion of these costs. For example, a 20% co-insurance rate, typical for basic Medicare coverage, leaves patients responsible for more than $20,000 of chemotherapy costs,…
At long last, my new book Critical Decisions is out there, ready to reach (fingers crossed!) a wide and appreciative audience. I’m really excited about this book. It pulls together ideas that have been smoldering in my brain for two decades — research, reflections and experiences (AKA “stories”). In the book, I relate the fascinating…
In this two-minute video, I explained why it can be hazardous to take a guess at what your lifetime risk is of experiencing cancer. I describe a study I conducted with, among others, Angie Fagerlin. This is one of my favorite studies, because it is really counterintuitive and raises important questions about health communication and medical decision-making….
Many people die in ways, and even in locations, that go against their preferences. They don’t want to be put on ventilators and, yet, spend their last days in intensive care units tethered to breathing machines. They don’t want cardiopulmonary resuscitation (CPR), and, yet, receive full-on “codes” when their hearts stop.
Much of this unwanted care could be avoided if patients (aka: “people”) discussed their treatment preferences with their clinicians.
Here is a USA Weekend piece on the type of advice I give in Critical Decisions – how to make stronger connections with your doctor.